420 likes | 941 Views
Sedative Hypnotic Agents. Sedative Hypnotic Agents. Cause drowsiness and facilitates the initiation and maintenance of sleep Grouped with anti-anxiety agents Effects of these drugs are dose related Ideal hypnotic should meet the following criteria
E N D
Sedative Hypnotic Agents • Cause drowsiness and facilitates the initiation and maintenance of sleep • Grouped with anti-anxiety agents • Effects of these drugs are dose related • Ideal hypnotic should meet the following criteria • Transient decrease in the level of consciousness for the purpose of sleep without lingering effects • Have no potential for decreasing or arresting respirations even at high doses • Produce no abuse, addiction, tolerance or dependence
Classification of Hypnotics • An arbitrary classification is as follows • Benzodiazepines • Barbiturates • Others
Sedative Hypnotics • Benzodiazepines • Used as daytime anxiolytics, sleep inducers, anesthetics, anticonvulsants and muscle relaxants • Depending on the dose any benzodiazepine may be used as a hypnotic • The benzodiazepines were shown to bind to the GABAA receptors involved in the regulation of the chloride channel. • Studies suggest two subclasses of receptors BZ1 and BZ2 • It has been proposed that compounds specific for the BZ1 subclass would be “nonsedative” and the BZ2 subclass is responsible for the sedative-hypnotic character of the benzodiazepines.
Sedative Hypnotics - Benzodiazepines • Major advantage in that they are relatively safe • Fatalities from overdose is rare • Their tendency to interact with other drugs is less than that seen with other hypnotics
Benzodiazepine N at position 1 optimal for activity R2 – various alkyl substitutions R3 – O, S, N (2-carbonyl is optimal) Fuzed triazoloring at positions 1 &2 or an imidazolo ring may be present. In these compounds position 7 electron withdrawing groups are not required. Sedative Hypnotics
Benzodiazepine Alkyl group at 3 decreases activity, -OH retains activity Saturation of the 4,5 double bond or bond shift to 3,4 decreases activity Phenyl group at 5 enhances activity Electron withdrawing groups are required at position 7 (R1) Positions 6,8 & 9 should not be substituted Sedative Hypnotics
Benzodiazepine Substitution at 2’ or 6’ or both with electron withdrawing groups increase activity. Para substitution decreases activity tremendously Sedative Hypnotics
Estazolam (Prosom) Used as a sedative and hypnotic in the treatment of insomnia Increase total sleep Decrease nocturnal wakefullness, body movements, number of awakenings and sleep latency No active metabolite Sedative Hypnotics - Benzodiazepines
Triazolam (Halcion) Used as a sedative and hypnotic in the treatment of insomnia No active metabolite Oral benzodiazepine and has an intermediate rate of absorption High receptor binding affinity Ultra-short half life Hydroxylation of triazole methyl group makes an inactive metabolite Sedative Hypnotics - Benzodiazepines
Temazepam (Restoril) Has an inactive metabolite Absorbed slowly Rapidly metabolized Sedative Hypnotics - Benzodiazepines
Flurazepam (Dalmane) Induces impairment of motor function and has hypnotic properties Used to treat insomnia Has active metabolites Metabolized by N-dealkylation and hydroxylation a to the imine Oral benzodiazepine and is absorbed most rapidly Sedative Hypnotics - Benzodiazepines
Quazepam (Doral) Induces impairment of motor function and has hypnotic properties Used to treat insomnia Has active metabolites Metabolized by oxidation to the 2-oxo compound and then N-dealkylation Sedative Hypnotics - Benzodiazepines
Oxazepam(Serax) Prototype for the 3-hydroxy compounds Short duration of action Sedative Hypnotics - Benzodiazepines
Alprazolam (Xanax) Oxidative metabolism of the methyl group to the methyl alcohol followed by conjugation is rapid Short duration of action Highly potent on milligram basis Sedative Hypnotics - Benzodiazepines
Chlordiazepoxide (Librium) N-demethylation and hydrolysis of the condensed amidino group produces demoxepam an active metabolite with anticonvulsant properties. It is converted to nordazepam which is converted to oxepam which undergoes conjugation and then is excreted. Sedative Hypnotics - Benzodiazepines Demoxepam
Nordiazepam It is converted to norda1zepam which is converted to oxazepam which undergoes conjugation and then is excreted. Sedative Hypnotics - Benzodiazepines Oxazepam
Clorazepate (Tranxene) Prodrug Undergoes rapid loss of water then carboxylation to nordiazepam which is converted to oxazepam Sedative Hypnotics - Benzodiazepines
Diazepam (Valium) Metabolized by N-demethylation to nordazepam which is then metabolized ot oxazepam Sedative Hypnotics - Benzodiazepines
Lorazepam (Ativan) Recognized as the 2’ chloro substituted analog of oxazepam This substitution increases activity Sedative Hypnotics - Benzodiazepines
Midazolam Also an anesthetic Sedative Hypnotics - Benzodiazepines
Clonazepam (Klonopin) Also used in some seizures Treatment of panic disorder extensively metabolised by reduction to 7-amino-clonazepam and by N-acetylation to 7-acetamino-clonazepam. Hydroxylation at the C-3 position also occurs. Sedative Hypnotics - Benzodiazepines
Minimal use as sedative hypnotics due to toxicity Cause greater CNS depression Induces liver drug metabolizing enzymes Cause tolerance and dependence Some use as sedative hypnotics Primarily used as anesthetics and antiseizure drugs Sedative Hypnotics - Barbiturates 2 1 3 6 4 5
Sedative Hypnotics - Barbiturates • Act postsynaptically to promote GABA binding and prolong the mean open time of Cl ion channels by binding to a site other than the BD binding site or the GABA binding site 2 1 3 6 4 5
Sedative Hypnotics - Barbiturates • A good hypnotic must be a weak acid • 5,5-disubstituted barbituric acids, 5,5-disubstituted thiobarbituric acids and 1,5,5-trisubstituted barbituric acids possess acceptable hypnotic activity • Other substitutiona are inactive or produce convulsions 2 1 3 6 4 5
What would be the product of barbituric acid (structure shown) reacting with NaOH twice? Show the intermediate product as well. Sedative Hypnotics - Barbiturates 2 1 3 6 4 5
Sedative Hypnotics – Barbiturates 5,5-Disubstitution • As you increase the # of carbons, lipophilicity increases • Branching, unsaturation, replacement of alicyclic or aromatic substituents for alkyl substituents, halogens onn the alkyl substituents all increase lipid solubility • As lipophilicity increases, hydrophilicity decreases • Polar groups decreases lipid solubility
Sedative Hypnotics – Barbiturates Substitution on Nitrogen • Substitution on one imide hydrogen by an alkyl group increases lipid solubility • Quicker onset and shorter duration of action • As the size of the N-alkyl substituent increases the lipid solubility increases and hydrophilic character decreases • Attachment of large alkyl groups imparts convulsant properties • Alkyl substituents to both nigrogens makes the drug nonacidic and inactive
Sedative Hypnotics – Barbiturates Modification of Oxygen • Replacement of C-2 oxygen by sulfur increases lipid solubility • Onset of activity is rapid • Used as iv anesthetics
Phenobarbital (Luminal) 5-ethyl, 5-phenyl subst. Also anticonvulsant Mephobarbital (Metharbital) 3-methyl, 5-phenyl and 5-ethyl substituents N-dealklyated to phenobarbital Also anticonvulsant Barbiturates – Long Duration of Action (6+ hours)
Amobarbital (Amytal) 5-ethyl and 5-isopentyl substituents Sedative-hypnotic Has a water-soluble sodium salt Amobarbital Sodium (Alurate) Butabarbital Sodium (Butisol Sodium) Water-soluble salt of 5-sec-butyl-5-ethylbarbituric acid Sedative-hypnotic Barbiturates – Intermediate Duration of Action (3-6 hours)
Pentobarbital Sodium (Nembutal) 5-ethyl, 5-(1methylbutyl) substituents More rapid metabolism Secobarbital (Seconal) 5-allyl, 5-(1-methylbutyl) substituents More rapid metabolism Barbiturates – Short Duration of Action (less than 3 hours)
Zolpidem (Ambien) Short acting hypnotic Acts at the GABAA receptor Imidazolpyridine Binds with higher affinity at the BZR1 receptor Drug dependence Rapid onset and short elimination half life Metabolized to inactive metabolites Sedative Hypnotics - Nonbenzodiazepines
Zaleplon (Sonata) Oyrazolopyrimidine derivative Short half-life Interacts with the GABAA receptor at the BZR1 receptor Inactive metabolites Sedative Hypnotics - Pyrazolopyrimidine
Eszopiclone (Lunesta) Used for insomnia single chiral center with an (S)-configuration very slightly soluble in water, slightly soluble in ethanol, and soluble in phosphate buffer pyrrolopyrazine extensively metabolized by oxidation and demethylation Sedative Hypnotics Cyclopyrrolone
Ramelteon (Roxerem) Melatonin Receptor Agonist • Activates MT1 and MT2 receptors • Rapid onset of sleep with minimal rebound insomnia or withdrawal symptoms • (S)-enantiomer • freely soluble in organic solvents, slightly soluble in water • oxidation to hydroxyl and carbonyl derivatives, with secondary metabolism producing glucuronide conjugates
Flumazenil Antagonist at benzodiazepine binding sites on the GABAA receptor Blocks actions of benzodiazepines and zolpidem but not other sedative hypnotics Management of benzodiazepine overdose Sedative Hypnotics Benzodiazepine Antagonist
Buspirone (Buspar) 5-HT Receptor Agonist • Partial agonist at 5-HT receptors • Slow onset (1-2 weeks) • Minimal psychomotor impairment • No additive CNS depression with sedative-hypnotic drugs
Chloral Hydrate (Noctec) A diol Metabolized to an active metabolite (trichloroethanol) Metabolite responsible for prolonged hypnotic effect Sedative in non operating room procedures for pediatrics